Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
20 Dezembro 2023 - 6:05PM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced the company will participate in the
upcoming 42nd Annual J.P. Morgan Healthcare Conference in San
Francisco.
Guardant Health’s management is scheduled to present and
participate in a Q&A session on Monday, January 8, at 3:45 p.m.
Pacific Time / 6:45 p.m. Eastern Time. Interested parties may
access live and archived webcasts of the sessions on the
“Investors” section of the company website at:
www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision medicine company focused
on guarding wellness and giving every person more time free from
cancer. Founded in 2012, Guardant is transforming patient care by
providing critical insights into what drives disease through its
advanced blood and tissue tests, real-world data and AI analytics.
Guardant tests help improve outcomes across all stages of care,
including screening to find cancer early, monitoring for recurrence
in early-stage cancer, and helping doctors select the best
treatment for patients with advanced cancer. For more information,
visit guardanthealth.com and follow the company on LinkedIn, X
(Twitter) and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231220877639/en/
Investor Contact: investors@guardanthealth.com
Media Contact: Melissa Marasco press@guardanthealth.com
+1 650-647-3711
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024